Featured Research

from universities, journals, and other organizations

Gene information predicts survival time, possible new treatment options for lung-cancer patients

Date:
December 17, 2010
Source:
UT Southwestern Medical Center
Summary:
Researchers have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.

Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.

"Patient responses to cancer treatment vary widely and often depend on subtle biological differences among tumors," said Dr. David Mangelsdorf, chairman of pharmacology at UT Southwestern and co-lead author of the study, published Dec. 14 by PLoS Medicine.

"These findings are important because the ability to determine which genes are being expressed in each person's tumor, as well as a patient's likely survival time, can guide physicians to the most effective and appropriate personalized treatments," he said.

Researchers involved in the study at UT Southwestern and UT M.D. Anderson Cancer Center carefully microdissected lung tumors and adjacent healthy lung tissue from 30 patients. To determine which genes were active, they examined each sample for the presence of messenger ribonucleic acid (mRNA) associated with the 48 known genes for molecules called nuclear hormone receptors.

The research team then compared the set of active genes, also called a gene expression profile or gene signature, with the actual clinical outcome of each study patient. They found that the expression of genes for specific nuclear hormone receptors was an excellent predictor of which patients were likely to survive the longest. They validated their test by screening more than 500 additional lung-tumor samples and accurately predicting those patients' outcomes.

In particular, the presence of two nuclear receptors -- the short heterodimer partner (SHP) and the progesterone receptor (PR) -- in tumor tissue was predictive of a good prognosis. Patients with those so-called biomarkers in their cancer cells lived the longest.

In normal lung tissue, a good prognosis was associated with the presence of nuclear receptors called nerve growth factor induced gene B3 (NGFIB3) and mineralocorticoid receptor (MR).

Dr. Mangelsdorf, a National Academy of Sciences member who is a leading expert on nuclear receptors, said the investigators focused on screening for the activity of these 48 nuclear receptor genes because several of them are known to be involved in promoting or inhibiting cancer. In addition, drugs that target certain nuclear receptors already are being used as front-line therapy in humans against breast cancer, prostate cancer and acute leukemia.

"The goal of identifying these genetic signatures in lung cancer is not just to determine how long a cancer patient will live, but also to home in on the most relevant drug or therapy targets that act specifically on these particular gene products," said Dr. Mangelsdorf, who also is an investigator with the Howard Hughes Medical Institute.

The results are a significant step toward personalized medicine, said Dr. John Minna, director of the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and the W.A. "Tex" and Deborah Moncrief Jr. Center for Cancer Genetics who has been investigating the biology of lung cancer for more than 30 years.

"Our long-term goal is to be able to sample a patient's lung cancer and perform molecular tests that can predict both how a patient will do and, more importantly, the best treatment for that individual," said Dr. Minna, co-lead author of the study.

"We were amazed to find that the pattern of expression of nuclear receptors in both lung cancers and normal lung tissue were so predictive of a patient's outcome. Because available drugs already target so many of these receptors, our next step is to find out which drugs will kill lung cancer cells expressing these specific receptors."

Other UT Southwestern researchers involved in the study were lead authors Dr. Yangsik Jeong, a former graduate student and now assistant professor at the Yonsei University in Korea, and Dr. Yang Xie, assistant professor of clinical sciences; Dr. Guanghua Xiao, assistant professor of clinical sciences; and Dr. Luc Girard, assistant professor of pharmacology. Dr. Ignacio Wistuba at M.D. Anderson also contributed.

The research was funded by the HHMI, the National Institutes of Health, the Cancer Prevention and Research Institute of Texas, the Department of Defense, the Welch Foundation and the Gillson Longenbaugh Foundation.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yangsik Jeong, Yang Xie, Guanghua Xiao, Carmen Behrens, Luc Girard, Ignacio I Wistuba, John D Minna, David J Mangelsdorf. Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer. PLoS Medicine, 2010; 7 (12): e1000378 DOI: 10.1371/journal.pmed.1000378

Cite This Page:

UT Southwestern Medical Center. "Gene information predicts survival time, possible new treatment options for lung-cancer patients." ScienceDaily. ScienceDaily, 17 December 2010. <www.sciencedaily.com/releases/2010/12/101214181926.htm>.
UT Southwestern Medical Center. (2010, December 17). Gene information predicts survival time, possible new treatment options for lung-cancer patients. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2010/12/101214181926.htm
UT Southwestern Medical Center. "Gene information predicts survival time, possible new treatment options for lung-cancer patients." ScienceDaily. www.sciencedaily.com/releases/2010/12/101214181926.htm (accessed August 20, 2014).

Share This




More Health & Medicine News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
American Ebola Patient Apparently Improving, Outbreak Is Not

American Ebola Patient Apparently Improving, Outbreak Is Not

Newsy (Aug. 19, 2014) Nancy Writebol, an American missionary who contracted Ebola, is apparently getting better, according to her husband. The outbreak, however, is not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins